UGA Bulletin Logo

Drug Targets in Signal Transduction Pathways


Course Description

Cellular mechanisms of signal transduction by multiple pathways, with specific emphasis on sites for therapeutic intervention and manipulation. Function, regulation, and structure of the components of the pathway including current or potential strategies to pharmacologically manipulate components of the pathway.


Athena Title

SIGNAL TRANSDUCTION


Prerequisite

Permission of department


Semester Course Offered

Offered fall


Grading System

A - F (Traditional)


Student learning Outcomes

  • In this course, students will learn the cellular mechanisms of signal transduction by multiple pathways, with specific emphasis on sites for therapeutic intervention and manipulation. For each signaling pathway, the current knowledge of the function, regulation, and structure of the components of the pathway will be discussed, and the relevance of the pathway to physiology and pathology will be explored. Drugs that impinge on these signaling pathways that are currently in clinical use will be presented, as well as potential therapeutic targets that are the focus of current research and drug development. In each of the lecture sections outlined below, two relevant papers from the primary scientific literature will be presented and discussed by the students.
  • Course Objectives For major signaling pathways and drug target classes discussed in this course, it is expected that student will gain mastery of the following objectives by the end of the semester and be able to do the following:
  • Develop a mechanistic understanding of cellular signaling pathways underlying normal physiology and disease states, enabling identification of critical nodes that serve as potential therapeutic targets.
  • Critically evaluate current and emerging drug targets within signal transduction networks, including kinases, receptors, transcription factors, and protein–protein interactions, with emphasis on their translational relevance.
  • Analyze gaps in knowledge across signaling pathways in complex diseases (e.g., cancer, metabolic disorders, neurodegeneration) and propose innovative strategies for therapeutic intervention.

Topical Outline

  • Section I: Principles of Cell Signaling and Drug Targeting, and GPCR signaling Introduction to signal transduction mechanisms GPCRs, heterotrimeric G proteins, cAMP Signaling New Frontiers in GPCR Signaling
  • Section II: Kinases - Receptor/Non-receptor and Serine-Theronine/Tyrosine Kinases Protein Kinases ‘A and G’, CAMK Phospholipase C, DAG, IP3, Ca2+ and Protein Kinase-C Cell Stress-related kinases (MAPK, SAPK, JUNK) PI 3-kinase, Protein Kinase-B, and eNOS signaling Mammalian Target of Rapamycin and AMP-Kinase pathways
  • Section III: Impact of cell signaling homeostasis, pathologies, and mesenchymal transition Cell polarity and cell junctions Vascular permeability, normalization, and cancer metastasis Cellular integrins: Affinity and avidity modulation
  • Section IV: The role of cytoskeleton in cellular signaling and pathophysiology Cytoskeletal remodeling in cell adhesion and motility TGFβ and BMP signaling in physiology and pathology Cellular differentiation: Mesenchymal cells and myofibroblasts in health and disease
  • Section V: Cell signaling in inflammation Mechanisms of T-cell differentiation in inflammation Pathways regulating Cell cycle and Proliferation Polyamine metabolism and signaling

Syllabus


Public CV